Best Life Sciences Companies in Fort Lauderdale, United States
The 33 best Life Sciences companies in Fort Lauderdale, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: OrthoSensor.
Our analysis of 164 Life Sciences companies
$34.7b in tracked funding; 83% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Life Sciences companies in Fort Lauderdale
| # | Company | Last round | Disclosed funding | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 3sync 3Sync is a medical research center that provides clinical trial services. | — | — | Private | 7 | — | WordPressApple iCloud MailMicrosoft 365+20 | — | — |
| 2 | Alkali Scientific Online store offering laboratory supplies and equipment | — | — | Unfunded | 22 22 → 17 (-23%) | — | Shogun Page BuilderCart FunctionalityBigCommerce+40 | — | — |
| 3 | bgasoft BGASoft offers business analysis, project management, software consulting, software development, and software… | — | — | Private | 18 | — | — | — | — |
| 4 | Gene2Know Provider of pharmacogenomics services for personalized medicine | — | — | Deadpooled | — | Gloydian Cruz CEO | — | — | — |
| 5 | Home Diagnostics Developer of home blood glucose monitor | — | — | Acquired | — | Scott Verner CEO | — | 214 patents Point‑of‑care diagnostic test strips and biosensor devices for blood analyte measurement | — |
| 6 | innomed technologies Medical technology development company | — | — | Acquired | 24 | — | — | 38 patents Patents concentrated in health & consumer products | — |
| 7 | Life Extension Science-based vitamins, supplements, and lab tests for optimal health | — | — | Funding Raised | 473 473 → 497 (+5%) | — | SitecoreCart FunctionalityMicrosoft ASP.NET+35 | 31 patents Blood purification and therapeutic devices for extracorporeal treatment of patient blood | — |
| 8 | LifeSync Corporation Digital remote health monitoring tool for providers | — | — | Unfunded | 19 | Kim Davis CEO | — | 34 patents Radiolucent, X‑ray‑transparent ECG electrode assemblies and wireless ECG monitoring systems | — |
Top 12 Life Sciences companies in Fort Lauderdale
#1
Series A · Fort Lauderdale, Florida · founded 2018 · 9 employees$5Mraised▾
Developer of intraoperative precision robotics for neurosurgery. It develops a portable MRI-compatible surgical robot for use in the MRI Suite, operating rooms, and surgeries which include brain cancer and functional brain disorders.
- Jun 2025Series A$8.1M
- Mar 2023Series A$1.6M
- Aug 2022Series A—
- Feb 2022Series A$3.4M
#2
Series A · Fort Lauderdale, Florida · founded 2020 · 13 employees$14.2Mraised▾
Developer of therapeutic vaccines for the treatment of cancer. The company has developed Syncrovax platform by utilizing intratumoral sync technology (IST) to design cancer therapies. The product pipeline includes NSC-IST, BRC-IST, OVN-IST, PRC-IST for the treatment of lung, breast, ovarian, and breast cancers.
- Dec 2024Series A$144.8M
- Nov 2022Series A$14.2M
#3
Series D · Fort Lauderdale, Florida · founded 2013 · 135 employees$111.9Mraised▾
Developer of a minimally invasive robotic surgery device. It offers Anovo Surgical System for laparoscopic-assisted transvaginal benign gynecologic procedures.
- Nov 2023Series D$5.9M
- Aug 2022Series D$4.4M
- Nov 2021Series D$96M
- Mar 2018Series A$10M
#4
Acqui-Hired · Fort Lauderdale, Florida · founded 2006 · 92 employees$122.6Mraised▾
OrthoSensor develops intelligent orthopedic devices and data services that provide quantitative feedback to surgeons and hospitals to assess their patients. Its flagship product Verasense is a disposable sensor-assisted total knee replacement instrument that delivers data wirelessly and enables surgeons to make evidence-based decisions on ligament/soft tissue balance and implant placement in real time.
- Nov 2020Series C$1.5M
- Oct 2020Series C$6.5M
- Oct 2020Conventional Debt$1.3M
- May 2020Series C$6.3M
#5
Series A · Fort Lauderdale, Florida · founded 2014 · 13 employees$31.5Mraised▾
Recros Medica develops rotational fractional resection devices, for aesthetic medicine. The company aims to demonstrate decreased skin laxity and improved focal contour by removing excess skin and fat. The devices are minimally invasive, handheld and will be utilized with either a single scalpet (tiny rotating cutting tube) or a multi-scalpet array to directly remove small plugs of skin (Pixels) in areas of skin laxity or undesired focal contour. Some of the applications include correction of sagging, lax skin in areas like the double chin deformity.
- Nov 2019Series A$14M
- Feb 2019Series A$4.1M
- Jan 2018Series A$9M
- Jul 2017Series A$4.4M
#6
Series B · Fort Lauderdale, Florida · founded 2011 · 26 employees$29.8Mraised▾
Vigilant Biosciences is a developer of solutions that aid in the early detection and intervention of cancer. Its point-of-care and lab solutions aim to empower healthcare practitioners to assess the risk of early to late stage oral cancer, and improve outcomes through earlier intervention. Vigilant Biosciences' OncAlert Oral Cancer System is based on patented technology that detects specific CD44 and Total Protein markers known to indicate an elevated risk for oral cancer, even prior to the observation of visual or physical symptoms. The simple, oral rinse procedure is easy to administer and non-invasive for the patient. The Oral Cancer System is currently under the CE Mark registration approval process.
- May 2018Series B$17.3M
- Feb 2016Series B$5M
- Mar 2015Series B$5.5M
- Mar 2014Conventional Debt$300K
#7
Funding Raised · Fort Lauderdale, Florida · founded 2006 · 10 employees$27.1Mraised▾
Innovative supplement delivery systems and clinically studied ingredients contract manufacturer. Specializing in custom manufacturing of high-quality dietary supplements and nutraceuticals for health and wellness brands. They offer end-to-end services, from formulation development to finished goods, focusing on novel, high-quality delivery forms and clinically backed ingredients. Their expertise spans various delivery forms, including gummies, beadlets, effervescents, powders, and encapsulation. They provide scalable manufacturing solutions, ensuring consistent quality and adherence to GMP standards. They are committed to developing customized dietary supplements that align with brand visions and meet consumer demands, leveraging research and development, quality teams, and regulatory compliance. They offer multiple format contract manufacturing and on-trend packaging solutions.
- May 2020Conventional Debt$27.1M
#8
Series A · Fort Lauderdale, Florida · founded 1994 · 4 employees$25Mraised▾
Innovating non-invasive laser breast imaging technology for early detection. The company focuses on research, development, and marketing of a non-invasive breast imaging system utilizing Computed Tomography Laser Mammography (CTLM). This technology aims to image normal and abnormal vasculature patterns within the breast, associated with malignant lesions, without breast compression or ionizing radiation. It serves as an adjunct to mammography, particularly beneficial for women with dense breasts. The goal is to provide a more comfortable and effective method for early breast abnormality detection, contributing to improved healthcare outcomes. The company is a medical device company.
- Aug 2000Series A$25M
#9
Public · Fort Lauderdale, Florida · founded 1993 · 4 employees$3.8Mraised▾
KAYA is engaged in production, distribution and sell cannabis product. The company is a holding company operates through its brands. It offers cannabis products in the form of a flower, concentrates, cannabis-infused foods, and topical creams. The company has vertically integrated cannabis business which includes retail, delivery, farming, and manufacturing.
- Oct 2021Post IPO$1.2M
- May 2021Post IPO$500K
- Jan 2017Post IPO$2.1M
#10
Seed · Fort Lauderdale, Florida · founded 2020 · 8 employees$2.3Mraised▾
{}
- Dec 2020Conventional Debt$551.2K
- Jun 2020Seed$2.3M
#11
Series A · Fort Lauderdale, Florida · founded 2003 · 12 employees$3.7Mraised▾
Ogenix is the manufacturer of EPIFLO, an FDA cleared, 3 ounce, 24/7 oxygen therapy which effectively treats many chronic wounds such as diabetic foot ulcers, venous stasis, pressure sores or bed sores (decubitus), surgical wounds, burns and many others.
#12
Seed · Fort Lauderdale, Florida · founded 2015$2Mraised▾
Developer of topical solutions addressing unmet needs in dermatology. The company focuses on researching and developing therapeutic solutions. Its pipeline includes products and clinical trials related to various dermatological conditions. The company's work involves randomized trials to assess efficacy and safety.
- Sep 2016Seed$2M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Life Sciences coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.